Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
Masashi IshikawaAtsuo TakashimaYusuke NagataRyoichi SawadaMasahiko AokiHiroshi ImazekiHidekazu HiranoHirokazu ShojiYoshitaka HonmaSatoru IwasaNatsuko OkitaKen KatoMasayuki SarutaNarikazu BokuPublished in: PloS one (2021)
We found that Re-Cx may have some anti-tumor efficacy as salvage treatment for mCRC and these results also suggested the clinical benefits of Re-Cx.